Your search for mar returned 314 results

However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.

Among those receiving two doses of the Moderna vaccine, peak vaccine efficacy against symptomatic COVID-19 was estimated to be 94.1% at 120 days after the first dose.

A higher risk was seen among women and among individuals aged 30 to 69 years.

There was a reduction in risk of admission and deaths with prior two-dose vaccination versus no vaccination.

Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.

An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.

A model shows the vaccine tied to the prevention of 110,000 deaths and a resulting $30.4 billion direct healthcare cost savings.

HHS expected to renew federal public health emergency beyond July … Report: California older adults lack affordable long-term care options … Scam screener helps physicians detect older adults at risk...

COVID-19 vaccination rates among nursing home staff jumped 25 percentage points nationally thanks in no small part to a CMS mandate imposed earlier this year.

With safer two-dose vaccines such as Pfizer and Moderna widely available, the one-dose J&J shot should be limited, the FDA said.